Form 4: TriSalus Life Sciences Director Receives Stock Units in Lieu of Cash Retainer

Director David J. Matlin received 10,040 restricted stock units in TriSalus Life Sciences in lieu of his 2025 cash board retainer.

Summary

• David J. Matlin, a director at TriSalus Life Sciences, received 10,040 restricted stock units (RSUs) on January 2, 2025.
• These RSUs were granted in place of his 2025 annual cash board service retainer.
• The RSUs will vest in equal quarterly installments on March 31, June 30, September 30, and December 31, 2025, contingent on his continued service as a director.
• Following this transaction, Mr. Matlin beneficially owns 941,944 shares of TriSalus Life Sciences common stock.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally positive for aligning director and shareholder interests. There are no negative implications.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages continued service and commitment from the director.

Future Outlook

The director's continued service is tied to the vesting of the RSUs, suggesting ongoing engagement with the company.

Industry Context

The use of stock-based compensation for board members is a common practice in the biotech industry to align interests with shareholders and conserve cash.

Comparison to Industry Standards

• Granting stock options or restricted stock units to board members is a standard practice in the biotech industry, similar to companies like Amgen, Gilead Sciences, and Regeneron.
• The vesting schedule of the RSUs is typical, with quarterly vesting being a common approach to incentivize long-term commitment.
• The value of the grant is not disclosed, but the number of shares is consistent with typical board compensation packages in similar sized companies.

Stakeholder Impact

• Shareholders may view the stock grant positively as it aligns the director's interests with the company's long-term success.
• The company conserves cash by issuing stock instead of paying a cash retainer.

Key Dates

Keywords

TriSalus Life Sciences, Director, Restricted Stock Units, RSU, Stock Grant, Board Retainer, Vesting, Equity Compensation